Shares of EliLilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P500's biggest decliner. The problem is that the drug giant provided ...
AJ Mast / Bloomberg via Getty Images The S&P500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's consumer price report. Eli ...
EliLilly's operational performance is strong ... shares have seen downside of 14.8% at a time when the S&P500 is up 2.6%. The picture isn't as bad when we compare the data to my original ...
Leerink Partners analyst David Risinger maintained a Buy rating on EliLilly & Co (LLY – Research Report) on January 24 and set a price target of $950.00. David Risinger has given his Buy rating ...
Some results have been hidden because they may be inaccessible to you